A meta-analysis of 34 studies reported pooled diagnostic accuracy for blood GFAP in distinguishing AD from controls, which was higher than that of CSF GFAP, although its performance improved when combined with demographic factors such as sex, age, and the APOE genotype [12]. Here, GFAP is linked to Alzheimer disease.